UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 111

Sortiert nach

GLP-2 regulation of intestinal lipid handling

Frontiers in physiology, 2024-02, Vol.15, p.1358625-1358625

2024

Volltextzugriff (PDF)

Sodium Phenylbutyrate, a Drug With Known Capacity to Reduce Endoplasmic Reticulum Stress, Partially Alleviates Lipid-Induced Insulin Resistance and β-Cell Dysfunction in Humans

Diabetes (New York, N.Y.), 2011-03, Vol.60 (3), p.918-924

2011

Volltextzugriff (PDF)

Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol

Diabetes (New York, N.Y.), 2016-07, Vol.65 (7), p.1767-1778

2016

Volltextzugriff (PDF)

Multi-organ Coordination of Lipoprotein Secretion by Hormones, Nutrients and Neural Networks

Endocrine reviews, 2021-12, Vol.42 (6), p.815-838

2021

Volltextzugriff (PDF)

Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms

Cellular and molecular gastroenterology and hepatology, 2019-01, Vol.7 (3), p.487-501

2019

Volltextzugriff (PDF)

Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans

Arteriosclerosis, thrombosis, and vascular biology, 2012-06, Vol.32 (6), p.1513

2012

Volltextzugriff (PDF)

Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism

Diabetes (New York, N.Y.), 2015-07, Vol.64 (7), p.2310-2318

2015

Volltextzugriff (PDF)

Gut-liver interaction in triglyceride-rich lipoprotein metabolism

American journal of physiology: endocrinology and metabolism, 2011-09, Vol.301 (3), p.E429-E446

2011

Volltextzugriff (PDF)

Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans

Diabetes (New York, N.Y.), 2014-07, Vol.63 (7), p.2394-2401

2014

Volltextzugriff (PDF)

New and emerging regulators of intestinal lipoprotein secretion

Atherosclerosis, 2014-04, Vol.233 (2), p.608-615

2014

Volltextzugriff (PDF)

Role of the Gut in Diabetic Dyslipidemia

Frontiers in endocrinology (Lausanne), 2020-03, Vol.11, p.116-116

2020

Volltextzugriff (PDF)

Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans

Arteriosclerosis, thrombosis, and vascular biology, 2013-05, Vol.33 (5), p.1056

2013

Volltextzugriff (PDF)

Control of intestinal lipoprotein secretion by dietary carbohydrates

Current opinion in lipidology, 2018-02, Vol.29 (1), p.24-29

2018

Volltextzugriff (PDF)

Effects of Acute Hyperglucagonemia on Hepatic and Intestinal Lipoprotein Production and Clearance in Healthy Humans

Diabetes (New York, N.Y.), 2011-02, Vol.60 (2), p.383-390

2011

Volltextzugriff (PDF)

Of the milk sugars, galactose, but not prebiotic galacto-oligosaccharide, improves insulin sensitivity in male Sprague-Dawley rats

PloS one, 2017-02, Vol.12 (2), p.e0172260-e0172260

2017

Volltextzugriff (PDF)

Is Insulin Action in the Brain Relevant in Regulating Blood Glucose in Humans?

The journal of clinical endocrinology and metabolism, 2015-07, Vol.100 (7), p.2525-2531

2015

Volltextzugriff (PDF)

Insulin Acutely Inhibits Intestinal Lipoprotein Secretion in Humans in Part by Suppressing Plasma Free Fatty Acids

Diabetes (New York, N.Y.), 2010-03, Vol.59 (3), p.580-587

2010

Volltextzugriff (PDF)

Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance

Cell reports (Cambridge), 2016-07, Vol.16 (3), p.717-730

2016

Volltextzugriff (PDF)

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor

Frontiers in cardiovascular medicine, 2020-06, Vol.7, p.100-100

2020

Volltextzugriff (PDF)

C‐reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen‐activated protein kinases

Hepatology (Baltimore, Md.), 2011-01, Vol.53 (1), p.127-135

2011

Volltextzugriff (PDF)

Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans

Circulation (New York, N.Y.), 2008-05, Vol.117 (18), p.2369-2376

2008

Volltextzugriff (PDF)

Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux

Communications biology, 2022-02, Vol.5 (1), p.132-132, Article 132

2022

Volltextzugriff (PDF)

Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes

Arteriosclerosis, thrombosis, and vascular biology, 2012-04, Vol.32 (4), p.1039

2012

Volltextzugriff (PDF)

Dietary carbohydrates and intestinal lipoprotein production

Current opinion in clinical nutrition and metabolic care, 2014-07, Vol.17 (4), p.355-359

2014

Volltextzugriff (PDF)

Release of Lipids Stored in the Intestine by Glucagon-Like Peptide-2 Involves a Gut-Brain Neural Pathway

Arteriosclerosis, thrombosis, and vascular biology, 2024-01, Vol.44 (1), p.192

2024

Volltextzugriff (PDF)

1 – 25 von 111

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(98)
Mit Volltextzugriff
(94)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

GLP-2 regulation of intestinal lipid handling

Sodium Phenylbutyrate, a Drug With Known Capacity to Reduce Endoplasmic Reticulum Stress, Partially Alleviates Lipid-Induced Insulin Resistance and β-Cell Dysfunction in Humans

Pharmacological Targeting of the Atherogenic Dyslipidemia Complex: The Next Frontier in CVD Prevention Beyond Lowering LDL Cholesterol

Multi-organ Coordination of Lipoprotein Secretion by Hormones, Nutrients and Neural Networks

Regulation of Chylomicron Secretion: Focus on Post-Assembly Mechanisms

Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans

Gut Peptides Are Novel Regulators of Intestinal Lipoprotein Secretion: Experimental and Pharmacological Manipulation of Lipoprotein Metabolism

Gut-liver interaction in triglyceride-rich lipoprotein metabolism

Sitagliptin, a DPP-4 Inhibitor, Acutely Inhibits Intestinal Lipoprotein Particle Secretion in Healthy Humans

New and emerging regulators of intestinal lipoprotein secretion

Role of the Gut in Diabetic Dyslipidemia

Novel role of enteral monosaccharides in intestinal lipoprotein production in healthy humans

Control of intestinal lipoprotein secretion by dietary carbohydrates

Effects of Acute Hyperglucagonemia on Hepatic and Intestinal Lipoprotein Production and Clearance in Healthy Humans

Of the milk sugars, galactose, but not prebiotic galacto-oligosaccharide, improves insulin sensitivity in male Sprague-Dawley rats

Is Insulin Action in the Brain Relevant in Regulating Blood Glucose in Humans?

Insulin Acutely Inhibits Intestinal Lipoprotein Secretion in Humans in Part by Suppressing Plasma Free Fatty Acids

Nucleic Acid-Targeting Pathways Promote Inflammation in Obesity-Related Insulin Resistance

Glycemia and Atherosclerotic Cardiovascular Disease: Exploring the Gap Between Risk Marker and Risk Factor

C‐reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen‐activated protein kinases

Both Intestinal and Hepatic Lipoprotein Production Are Stimulated by an Acute Elevation of Plasma Free Fatty Acids in Humans

Macrophage Jak2 deficiency accelerates atherosclerosis through defects in cholesterol efflux

Absence of acute inhibitory effect of insulin on chylomicron production in type 2 diabetes

Dietary carbohydrates and intestinal lipoprotein production

Release of Lipids Stored in the Intestine by Glucagon-Like Peptide-2 Involves a Gut-Brain Neural Pathway

Suchergebnisse filtern